From 6 May 2024, pharmacists in South Australia can provide women who meet certain criteria with a resupply of the oral contraceptive pill (OCP) without a doctor’s prescription. It is important to note that this is not a trial; pharmacists...
PDL members are kept notified via our regular email notices called Practice Alerts. We bring awareness to potential risks that could impede on the pharmacy profession. They are often sent reactively, from trends and incident reports conducted by PDL and other influencing bodies, in a bid to help our members avoid an incident. They can be national alerts or state-specific if connected to local legislation.
A wide range of guides and resources are also available to PDL members that have been developed to support pharmacists in their daily practice.
From 6 May 2024, pharmacists in South Australia can provide women who meet certain criteria with a resupply of the oral contraceptive pill (OCP) without a doctor’s prescription. It is important to note that this is not a trial; pharmacists...
In recent years, the pharmacy profession has seen significant expansion in the range of medicines that pharmacists can administer by injection. The scope has broadened to encompass different age groups and medicines, via different routes of injection. PDL guide to...
Meridian Lawyers has collaborated with PDL to prepare an article about professional boundaries and the types of conduct that are likely to be the subject of complaint to regulators. The article references Ahpra’s 2022/23 annual report, which revealed 841 notifications...
PDL Professional Officers occasionally receive incident reports and notifications relating to breaches or concerns regarding access to a patient’s My Health Record. Some of these cases require responses to the Australian Digital Health Agency (ADHA) and/or the Office of the...
Recent legislative change now allows Northern Territory pharmacists to provide antibiotic treatment without a prescription from a prescriber for uncomplicated urinary tract infections (UTIs), to patients who meet certain criteria....
PDL has chosen to describe the charting and prescribing activity by hospital pharmacists as Collaborative Pharmacist-led Charting and Prescribing (CPCP), though it may also be known as Partnered Pharmacist Medication...
This Practice Alert highlights some recent practice issues reported to PDL Professional Officers. Respiratory Syncytial Virus (RSV) vaccines Currently, two Respiratory Syncytial Virus (RSV) vaccines, Arexvy® and Abrysvo®, have been...
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.
